快速启动的科学——从抗逆转录病毒治疗开始的时机到方法
The science of rapid start-From the when to the how of antiretroviral initiation.
作者信息
Geng Elvin H, Havlir Diane V
机构信息
Division of HIV, Infectious Diseases and Global Medicine, Department of Medicine, Zuckerberg San Francisco General Hospital, University of California, San Francisco, California, United States of America.
出版信息
PLoS Med. 2017 Jul 25;14(7):e1002358. doi: 10.1371/journal.pmed.1002358. eCollection 2017 Jul.
Abstract
In this Perspective linked to Koenig and colleagues, Elvin Geng and Diane Havlir discuss the next challenges for implementation research around rapid start antiretroviral treatment.
摘要
在这篇与凯尼格及其同事相关的观点文章中，埃尔文·耿和黛安·哈弗利尔探讨了围绕快速启动抗逆转录病毒治疗的实施研究面临的下一批挑战。
相似文献
1
The science of rapid start-From the when to the how of antiretroviral initiation.
PLoS Med. 2017 Jul 25;14(7):e1002358. doi: 10.1371/journal.pmed.1002358. eCollection 2017 Jul.
2
Improving tuberculosis control: an interdisciplinary approach.
Lancet. 2006 Mar 18;367(9514):949-50. doi: 10.1016/S0140-6736(06)68390-6.
3
Current world literature.
Curr Opin HIV AIDS. 2012 Jul;7(4):376-81. doi: 10.1097/COH.0b013e3283550928.
4
A clinician's perspective: when to start antiretroviral treatment and when to change therapy.
J Biol Regul Homeost Agents. 1995 Jul-Sep;9(3):114-8.
5
Simplifying and adapting antiretroviral treatment in resource-poor settings: a necessary step to scaling-up.
AIDS. 2004 Dec 3;18(18):2353-60.
6
When to start antiretroviral therapy: a swinging pendulum?
Top HIV Med. 2008 Jun-Jul;16(2):82-8.
7
Rape survivors and the provision of HIV post-exposure prophylaxis.
S Afr Med J. 2007 Aug;97(8):585-6.
8
Viral response to antiretroviral therapy in a patient coinfected with HIV type 1 and type 2.
Clin Infect Dis. 2005 Jul 15;41(2):e19-21. doi: 10.1086/431204. Epub 2005 May 31.
9
Economic research on HIV prevention, care and treatment: why it is more than ever needed?
Curr Opin HIV AIDS. 2010 May;5(3):201-3. doi: 10.1097/COH.0b013e328338b960.
10
[Antiretroviral treatment: when to start and with what?].
Med Clin (Barc). 1998 Jul 4;111(4):137-41.
引用本文的文献
1
Instrumental variables for implementation science: exploring context-dependent causal pathways between implementation strategies and evidence-based interventions.
Implement Sci Commun. 2023 Dec 20;4(1):157. doi: 10.1186/s43058-023-00536-x.
2
HIV test-and-treat policy improves clinical outcomes in Zambian adults from Southern Province: a multicenter retrospective cohort study.
Front Public Health. 2023 Oct 11;11:1244125. doi: 10.3389/fpubh.2023.1244125. eCollection 2023.
3
The Rapid interaction: a qualitative study of provider approaches to implementing Rapid ART.
Implement Sci Commun. 2023 Jul 14;4(1):78. doi: 10.1186/s43058-023-00464-w.
4
Effects of implementing universal and rapid HIV treatment on initiation of antiretroviral therapy and retention in care in Zambia: a natural experiment using regression discontinuity.
Lancet HIV. 2021 Dec;8(12):e755-e765. doi: 10.1016/S2352-3018(21)00186-7. Epub 2021 Oct 14.
5
The Impact of Same-Day Antiretroviral Therapy Initiation Under the World Health Organization Treat-All Policy.
Am J Epidemiol. 2021 Aug 1;190(8):1519-1532. doi: 10.1093/aje/kwab032.
6
Effectiveness of same-day antiretroviral therapy initiation in retention outcomes among people living with human immunodeficiency virus in Ethiopia: empirical evidence.
BMC Public Health. 2020 Nov 26;20(1):1802. doi: 10.1186/s12889-020-09887-9.
7
Rapid antiretroviral therapy initiation in the Botswana Combination Prevention Project: a quasi-experimental before and after study.
Lancet HIV. 2020 Aug;7(8):e545-e553. doi: 10.1016/S2352-3018(20)30187-9.
8
Initiation of Antiretroviral Therapy in the Hospital Is Associated With Linkage to Human Immunodeficiency Virus (HIV) Care for Persons Living With HIV and Substance Use Disorder.
Clin Infect Dis. 2021 Oct 5;73(7):e1982-e1990. doi: 10.1093/cid/ciaa838.
9
Longitudinal Care Cascade Outcomes Among People Eligible for Antiretroviral Therapy Who Are Newly Linking to Care in Zambia: A Multistate Analysis.
Clin Infect Dis. 2020 Dec 17;71(10):e561-e570. doi: 10.1093/cid/ciaa268.
10
Toward Universal HIV Treatment in Haiti: Time Trends in ART Retention After Expanded ART Eligibility in a National Cohort From 2011 to 2017.
J Acquir Immune Defic Syndr. 2020 Jun 1;84(2):153-161. doi: 10.1097/QAI.0000000000002329.
本文引用的文献
1
Same-day HIV testing with initiation of antiretroviral therapy versus standard care for persons living with HIV: A randomized unblinded trial.
PLoS Med. 2017 Jul 25;14(7):e1002357. doi: 10.1371/journal.pmed.1002357. eCollection 2017 Jul.
2
Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention.
N Engl J Med. 2016 Nov 3;375(18):1726-1737. doi: 10.1056/NEJMoa1511691.
3
Effects of a multicomponent intervention to streamline initiation of antiretroviral therapy in Africa: a stepped-wedge cluster-randomised trial.
Lancet HIV. 2016 Nov;3(11):e539-e548. doi: 10.1016/S2352-3018(16)30090-X. Epub 2016 Aug 27.
4
Interventions to improve the rate or timing of initiation of antiretroviral therapy for HIV in sub-Saharan Africa: meta-analyses of effectiveness.
J Int AIDS Soc. 2016 Aug 8;19(1):20888. doi: 10.7448/IAS.19.1.20888. eCollection 2016.
5
HIV infection.
Nat Rev Dis Primers. 2015 Oct 1;1:15035. doi: 10.1038/nrdp.2015.35.
6
A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa.
N Engl J Med. 2015 Aug 27;373(9):808-22. doi: 10.1056/NEJMoa1507198. Epub 2015 Jul 20.
7
The PRECIS-2 tool: designing trials that are fit for purpose.
BMJ. 2015 May 8;350:h2147. doi: 10.1136/bmj.h2147.
8
Retention in care under universal antiretroviral therapy for HIV-infected pregnant and breastfeeding women ('Option B+') in Malawi.
AIDS. 2014 Feb 20;28(4):589-598. doi: 10.1097/QAD.0000000000000143.
9
Timing of antiretroviral therapy for HIV-1 infection and tuberculosis.
N Engl J Med. 2011 Oct 20;365(16):1482-91. doi: 10.1056/NEJMoa1013607.
10
Prevention of HIV-1 infection with early antiretroviral therapy.
N Engl J Med. 2011 Aug 11;365(6):493-505. doi: 10.1056/NEJMoa1105243. Epub 2011 Jul 18.
Zotero 插件